Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade-Reply

JAMA Oncol. 2023 Apr 1;9(4):570-571. doi: 10.1001/jamaoncol.2022.7589.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Immunological* / therapeutic use
  • B7-H1 Antigen / genetics
  • Biomarkers, Tumor
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Humans
  • Immunotherapy
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Mutation

Substances

  • B7-H1 Antigen
  • Antineoplastic Agents, Immunological
  • Biomarkers, Tumor